Last reviewed · How we verify
Vital signs
Vital signs monitoring and tracking helps healthcare providers to assess a patient's overall health and detect any potential issues.
Vital signs monitoring and tracking helps healthcare providers to assess a patient's overall health and detect any potential issues. Used for Monitoring and tracking of vital signs in various settings, including hospitals, clinics, and emergency departments..
At a glance
| Generic name | Vital signs |
|---|---|
| Sponsor | NYU Langone Health |
| Modality | Biologic |
| Therapeutic area | General Medicine |
| Phase | FDA-approved |
Mechanism of action
Vital signs monitoring typically includes measuring parameters such as heart rate, blood pressure, respiratory rate, and body temperature. These measurements help healthcare providers to diagnose and manage various medical conditions, and to adjust treatment plans as needed.
Approved indications
- Monitoring and tracking of vital signs in various settings, including hospitals, clinics, and emergency departments.
Common side effects
Key clinical trials
- A Machine Learning Prediction Model for Postoperative Acute Kidney Injury in Non-Cardiac Surgery Patients
- A Pilot Study to Assess the Feasibility and Acceptability of Newborn Screening Using in Silico Panel-based Solo Genome Sequencing in France
- Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC) (NA)
- Regenerative Potentials of Mature Mandibular Molars With Symptomatic Irreversible Pulpitis Enhanced With Different Scaffolds (NA)
- Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management (PHASE2)
- TheraSphere With Durvalumab and Tremelimumab for HCC (PHASE2)
- RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms (PHASE2)
- The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vital signs CI brief — competitive landscape report
- Vital signs updates RSS · CI watch RSS
- NYU Langone Health portfolio CI